- Home
- CELH vs PODD Comparison
CELH vs PODD Comparison
Compare CELH & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CELH | PODD |
|---|---|---|
| Founded | 2004 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Medical/Dental Instruments |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.5B | 12.7B |
| IPO Year | 2008 | 2007 |
Fundamental Metrics
Financial Performance| Metric | CELH | PODD |
|---|---|---|
| Price | $33.55 | $167.16 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 17 | 21 |
| Target Price | $64.81 | ★ $341.48 |
| AVG Volume (30 Days) | ★ 6.1M | 1.0M |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.25 | ★ 3.48 |
| Revenue | $1,318,014,000.00 | ★ $2,708,100,000.00 |
| Revenue This Year | $37.04 | $24.55 |
| Revenue Next Year | $9.89 | $19.18 |
| P/E Ratio | $134.68 | ★ $49.35 |
| Revenue Growth | ★ 101.65 | 30.73 |
| 52 Week Low | $32.01 | $158.35 |
| 52 Week High | $66.74 | $354.88 |
Technical Indicators
Market Signals| Indicator | CELH | PODD |
|---|---|---|
| Relative Strength Index (RSI) | 41.81 | 27.38 |
| Support Level | $32.70 | N/A |
| Resistance Level | $37.40 | $205.95 |
| Average True Range (ATR) | 1.32 | 7.14 |
| MACD | 0.34 | -1.35 |
| Stochastic Oscillator | 34.50 | 18.50 |
Price Performance
Historical ComparisonAbout CELH Celsius Holdings Inc.
Celsius Holdings plays in the energy drink subsegment of the global nonalcoholic beverage market, with 95% of revenue concentrated in North America. The firm now owns three energy drink brands: Celsius, Alani Nu, and Rockstar Energy. It dedicates its efforts to product innovation and marketing while outsourcing manufacturing and packaging to third-party co-packers and distribution to PepsiCo. The firm issued convertible preferred shares following PepsiCo's investments in 2022 and 2025, giving the latter an 11% stake in Celsius.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.